BIOMAT Database Logo BIOMAT Database Logo

[Effect of 1-nitro-9-aminoalkylacridine (Ledakrin, C-283) binding with chromatin on DNA template activity (preliminary report)]. 1977

D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski

UI MeSH Term Description Entries
D009564 Nitracrine Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis. C-283,Ledakrin,C 283,C283
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000166 Acridines Compounds that include the structure of acridine. Acridine
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic

Related Publications

D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
January 1976, Materia medica Polona. Polish journal of medicine and pharmacy,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
In vitro DNA crosslinking by Ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine.
February 1997, Chemico-biological interactions,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Ledakrin--anticancerous medicine 1-nitro-9(3-dimethylaminopropylamino)-acridine -2HCl-H2O.
January 1976, Materia medica Polona. Polish journal of medicine and pharmacy,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
The mechanism of inhibition of DNA transcription in vitro by nitracrine (Ledakrin, C-283).
July 1979, Molecular pharmacology,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.
March 1981, Chemico-biological interactions,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
DNA damage in HeLa s3 cells by an antitumor drug Ledakrin and other antitumor 1-nitro-9-aminoacridines.
May 1984, Chemico-biological interactions,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Influence of thiols on inhibition of ribonucleic acid synthesis in vitro by a 1-nitro-9-aminoalkylacridine derivative, C-283.
May 1975, Molecular pharmacology,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Nuclear and nucleolar ultrastructural lesions induced by 1-nitro-9-aminoacridine (C-283) in human ovarian carcinoma cells.
January 1973, European journal of cancer,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
December 1984, Journal of biomolecular structure & dynamics,
D Wilmańska, and L Szmigiero, and S Malagocka, and B Jaros-Kamińska, and M Gniazdowski
Brain chromatin template activity in rats treated with delta 9-tetrahydrocannabinal.
May 1973, Canadian journal of physiology and pharmacology,
Copied contents to your clipboard!